The Week

Albemarle’s (ALB) weekly performance data was not provided for this period, so no week-over-week percentage change or closing price can be stated here. The latest real-time quote shows the stock around $104.59 in regular trading, with a modest dip to $104.42 in post-market hours. There is no daily bar data available to characterise the shape of the week, so this section stays with the latest price rather than making any inference about intraweek moves.

Key Events

Albemarle’s week was anchored by two things. On 1 October, the company announced it will report third-quarter 2026 earnings on Wednesday, 4 November 2026, putting the next company-specific catalyst on the calendar. Earlier, on 29 September, several industry pieces tied lithium to the shifting AI supply chain, framing packaging and lithium as the new physical constraints as compute demand evolves. Albemarle appeared in that value-chain reordering discussion as an upstream lithium supplier. Beyond this, there were no standalone product, partnership, or regulatory disclosures from the company this week.

Analyst Ratings

Coverage totals 22 institutions: 13 rate Albemarle a buy or overweight, 9 rate it hold, and none rate it underweight or sell. The consensus rating is buy, with a consensus target of $171.064, implying roughly 63.6% upside from the latest price of $104.59. The target range is wide, from $83.28 to $225.00, pointing to real disagreement among analysts about where lithium prices and earnings recovery settle. Within the specialty chemicals sector, Albemarle ranks 4th out of 37 companies in analyst rating.

The Week Ahead

The coming week is heavy on US macro data rather than company news. On Monday, 5 October, the S&P Global services PMI final reading and the ISM non-manufacturing PMI are due; the ISM figure has a prior of 55.4 and a forecast of 55. On Tuesday, 6 October, the international trade balance lands with a prior of -$88.6 and a forecast of -$102. Albemarle has no earnings or major corporate event on the calendar this week, leaving the next big catalyst at the 4 November Q3 report.

In Short

The analyst stance and the week’s lithium narrative sit in tension: a consensus target above spot with a wide range means conviction is thinner than the headline upside suggests. On valuation, a P/E around 214.9x and a P/B around 1.5x carry different meanings when the earnings base is thin, so the multiple cannot be read in isolation. The real signal comes on 4 November: how the company talks about cost, price, and shipment pace, plus whether macro data shifts the demand picture for lithium.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.